Tradestie Institutional Equity Comparison Engine

ATYR vs ACRS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (3โ€“0 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ATYR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ACRS at N/M Forward P/E and -1412.4% operating margin (-55.1% YoY). In options structure, ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro) against ACRS sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ATYR N/M vs ACRS N/M Fwd P/E
Growth & Margin Winner ATYR
Op Margin 0.0% vs -1412.4% ยท YoY +0.0% vs -55.1%
Momentum & Technical Winner ATYR
1Y +558.7% vs +34.3% ยท 52W Pos 62% vs 26%
Options & Structure Winner ATYR
UNCLASSIFIED (36th %ile IV) vs BREAKDOWN (1st %ile IV)
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.96
-5.34% 1D
Market Cap $15.6M
1M Return +2788.76%
1Y Return +558.7%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0
ACRS NASDAQ
Aclaris Therapeutics, Inc.
Pharmaceutical Preparations
$3.38
-6.1% 1D
Market Cap $621.8M
1M Return -2.73%
1Y Return +34.33%
Forward P/E N/M
Unified AI Score
44.7 / 100 HOLD
Tech 41.0 Fund 54.0 Flow 64.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATYR +558.7% ACRS +34.33% Spread: +524.37 pp (ATYR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ATYR Revenue ACRS Revenue ATYR Op. Margin ACRS Op. Margin Margin Edge
FY2018 N/A $10M N/A -1378.3% ACRS
FY2019 $0M $0M -5445.0% -2627.3% ACRS
FY2020 $10M $10M -152.2% -785.4% ATYR
FY2021 N/A $10M N/A -1327.1% ACRS
FY2022 $10M $30M -446.8% -302.0% ACRS
FY2023 $0M $30M -15557.8% -311.6% ACRS
FY2024 $0M $20M -28899.6% -758.2% ACRS
FY2025 $0M $10M -40856.3% -975.9% ACRS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATYR (3) vs ACRS (4)
Institutional Metric ATYR ACRS Criterion Row Winner
Market Capitalization Scale $15.6M $621.8M Larger Scale ACRS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -55.1% Higher Growth ATYR
Operating Margin (TTM) Profitability 0.0% -1412.4% Higher Margin ATYR
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -93.7% -55.5% Higher ROE ACRS
52-Week Range Position Momentum 62% ($0โ€“$8) 26% ($2โ€“$7) Stronger Trend ATYR
Beta / 30D Volatility Risk Regime -9.67ฮฒ ยท 13806% Vol 1.55ฮฒ ยท 73% Vol Lower Realized Risk ACRS
Unified Institutional Score Composite Signal 34.3 / 100 (SELL) 44.7 / 100 (HOLD) Higher Composite ACRS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATYR vs ACRS Buy Guide
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACRS BREAKDOWN
130d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 1st %ile
IV Regime Compressed (<25th %ile)
Live ACRS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATYR nor ACRS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.